ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc. is a specialty pharmaceutical company based in San Diego that focuses on the discovery, development, and marketing of small molecule drugs to address critical, unmet medical needs. The company currently markets four oncology and dermatology products in the United States, including ONTAK, Targretin capsules, Targretin gel, and Panretin gel. Its newest product, AVINZA, is a treatment for chronic, moderate-to-severe pain. Additionally, ACADIA Pharmaceuticals Inc. has a network of major pharmaceutical partners developing products for hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases.